Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Daratumumab as Maintenance After Peripheral Blood Stem Cell Transplantation From HLA-identical or Haploidentical Family Donor in the Treatment of Refractory or Relapsed Multiple Myeloma: a Phase 2 Trial

Assistance Publique - Hôpitaux de Paris · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
multiple-myeloma
multiple myeloma, myeloma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 874089
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.